It must be an and." Quick summary: Part 2 Reminder of Part 1 Prevalence & Demand: Single largest patient population of any chronic disease in the country Traditionally marginalized groups are more affected by it The numbers are growing Patients want a solution desperately Clinical Efficacy: Clinical trial data suggests benefits outweigh risks for certain patient populations Actions of healthcare providers suggest they strongly want patients to have access Pricing Timeline: Branded drug will start with monopolistic prices for ~decade The patent will eventually expire The bigger the market (outlined above), the more competition, the greater the percentage price decrease Take away from Part 1: over a long enough time period, the price will come down given high demand, regulatory precedent, and economic incentives
Medically reviewed by Charles Kamen, MD, board-certified neurologist Patients ask us this constantly: how much does peptide therapy cost in Las Vegas
Prescription GLP-1 vs
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS
Lilly refers to it as an investigational once-weekly triple hormone receptor agonist
Have the administrator send the requested cash-out amount to via paper check or ACH transfer
